Actively Recruiting
Phase III Trial of Emotion and Symptom-Focused Engagement EASE to Reduce Traumatic Stress in Parents Caring for Children With Cancer
Led by University Health Network, Toronto · Updated on 2025-12-17
306
Participants Needed
2
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of a new psychotherapeutic intervention called Emotion and Symptom-focused Engagement EASE for parents caring for a child or adolescent with cancer. This Phase III randomized controlled trial aims to determine if adding EASE to usual care can reduce traumatic stress symptoms over six months compared to usual care alone. The study focuses on parents of children diagnosed with cancer within the past six months. Participants are randomly assigned to one of two groups. One group receives the EASE intervention plus usual care, where EASE involves 8 to 12 therapy sessions lasting about 30 to 60 minutes each, delivered by trained mental health clinicians over 12 weeks. The other group receives usual care without the added therapy sessions. During the study, participants complete questionnaires at enrollment and then at 4, 8, and 12 weeks, as well as 6 months after enrollment. Optional interviews may be offered to better understand participant experiences. Researchers measure traumatic stress symptoms using tools like the Stanford Acute Stress Reaction Questionnaire and other health and psychological assessments. The total study duration for participants is six months, during which their progress and well-being are closely monitored.
CONDITIONS
Brief Title
Emotion and Symptom-Focused Engagement (EASE) for Caregivers
Research Team
D
Dr. Lindsay Jibb, RN, PhD
E
Elham Hashemi, MA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here